(Q44670060)

5 December 2017

title

miR-203 expression predicts outcome after liver transplantation for hepatocellular carcinoma in cirrhotic liver (English)

1 reference

5 December 2017

0 references

liver transplantation

1 reference

inferred from title

hepatocellular carcinoma

1 reference

Hong-Yuan Chen

1

1 reference

5 December 2017

Zhong-Bo Han

2

1 reference

5 December 2017

Jun-Wei Fan

3

1 reference

5 December 2017

Jun Xia

4

1 reference

5 December 2017

Jun-Yi Wu

5

1 reference

5 December 2017

Guo-Qiang Qiu

6

1 reference

5 December 2017

Hua-Mei Tang

7

1 reference

5 December 2017

Zhi-Hai Peng

8

1 reference

5 December 2017

publication date

24 July 2011

1 reference

5 December 2017

1 reference

5 December 2017

volume

29

1 reference

5 December 2017

issue

3

1 reference

5 December 2017

page(s)

1859-1865

1 reference

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

Liver transplantation for hepatocellular carcinoma: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

A MicroRNA targeting dicer for metastasis control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

MicroRNAs and cancer: short RNAs go a long way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

MicroRNA signature predicts survival and relapse in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

Survival prediction of gastric cancer by a seven-microRNA signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

The functions of animal microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

The role of microRNAs in liver cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

The MicroRNA miR-139 Suppresses Metastasis and Progression of Hepatocellular Carcinoma by Down-regulating Rho-Kinase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0031-9

Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies

21 January 2018

1 reference

12 December 2020

Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor

1 reference

12 December 2020

Liver transplantation for hepatocellular carcinoma

1 reference

12 December 2020

Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis

1 reference

12 December 2020

The relationship between Bmi-1 and the epithelial-mesenchymal transition in lung squamous cell carcinoma

1 reference

12 December 2020

Liver transplantation for hepatocellular carcinoma: Hangzhou experiences

1 reference

12 December 2020

10.1007/S12032-011-0031-9

Identifiers

DOI

1 reference

5 December 2017

1 reference